Well Told Grants

Federal grant programs / 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies

21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies in Washington

21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (93.372) awarded $33.0 million to recipients in Washington in 22 grants from fiscal 2021 to 2025, 7.1% of the program's national total. Allen Institute received the most, $21.9 million.

By year

Grants under this program to recipients in Washington
Fiscal yearAwardsAmount
FY 20215$708,666
FY 20224$2.9 million
FY 202312$10.1 million
FY 202411$9.7 million
FY 202516$9.6 million

Recipients in Washington

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
Allen InstituteColleges and universities14$21.9 million
University of WashingtonColleges and universities7$11.0 million

Counted by the recipient's location. A recipient based in Washington may carry out the work elsewhere.

Open opportunities under this program

See all 11 on the program page

Questions people ask

How much 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies money goes to Washington?

$33.0 million from fiscal 2021 to 2025, across 22 awards. Washington ranks 5th of 34 states and territories for this program.

Who receives 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies money in Washington?

The largest recipient is Allen Institute, with $21.9 million in 14 awards. Next is University of Washington.

Can organizations in Washington apply now?

Yes, 11 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies in other states

Other large programs in Washington

All federal grants in Washington

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.